Mental Illness Diagnostic Screening (R&D)

Advancing the Future of Healthcare Intelligence

QScreen AI is committed to advancing quantum-inspired artificial intelligence across healthcare screening, digital diagnostics, and predictive medicine.

Our multidisciplinary team of scientists, clinicians, engineers, and entrepreneurs is focused on building scalable, non-invasive technologies designed to strengthen safety, improve early detection, and support long-term health outcomes.


BUILDING A BETTER TOMORROW

Innovation at QScreen AI is driven by continuous research, strategic collaboration, and real-world validation.

We are actively evolving our existing screening infrastructure while developing next-generation diagnostic solutions. Working alongside institutional partners, research bodies, and healthcare professionals, we are expanding the capabilities of AI-powered signal intelligence.

Our R&D initiatives focus on:

• Enhanced multispectral detection models

• Advanced fatigue and impairment analytics

• AI-driven predictive health insights

• Scalable digital diagnostic frameworks

screen-research-and-development

NEW PRODUCT CONCEPT

Mental Illness Diagnostic Screening (R&D)

 

Mental illnesses are often difficult to identify in early stages. QScreen AI is developing a non-invasive, measurable screening tool designed to assist healthcare practitioners in detecting early indicators of:

• Depression

• Dementia

• Alzheimer’s disease

• Related neurological conditions

By applying advanced signal analysis and AI-driven pattern recognition, this research initiative aims to support earlier intervention and improved clinical decision-making.

 

COLLABORATE WITH US

 

If you have expertise in neuroscience, behavioral diagnostics, AI modeling, or related technologies, we welcome collaboration.

We are actively seeking clinical, academic, and technology partners to support validation, development, and commercialization of this emerging solution.